Although previous studies have reported that the behavior and prognosis of tumor patients may be influenced by immune infiltration (Zhu et al. 2023), the interaction mechanism between ENO2, IGF2BP3, and the tumor microenvironment (TME) in CRC remains unclear. The gene discussed is ENO2; the disease is neoplasm.